Document is current
Any future updates will be listed below
-
Authors
Peschl, Patrick
Schanda, Kathrin
Zeka, Bleranda
Given, Katherine
Böhm, Denise
Ruprecht, Klemens
Saiz, Albert
Lutterotti, Andreas
Rostásy, Kevin
Höftberger, Romana
Berger, Thomas
Macklin, Wendy
Lassmann, Hans
Bradl, Monika
Bennett, Jeffrey L.
Reindl, Markus https://orcid.org/0000-0003-2817-1402
-
Funding
Funding for this research was provided by:
Austrian Science Fund (W1206 SPIN, P28476-B30)
National Institutes of Health (EY022936, UM1AI110498)
Guthy-Jackson Charitable Foundation
La Marató de TV3 (20141830)
- License Information
-
More Information
Article History
Received: 7 September 2017
Accepted: 18 October 2017
First Online: 25 October 2017
Ethics approval and consent to participate
: This study was approved by the Ethical Committee of the Medical University of Innsbruck (study numbers AM3041A and AM4059) and by the Ethic Committees of the Hospital Clinic of Barcelona (2010/5680), Charite University Medicine Berlin (EA1/131/09) and University Hospital Zürich (KEK-Nr. 2013-0001). All patients or their caregivers gave informed written consent.
: Not applicable.
: The Medical University of Innsbruck and University Hospital Innsbruck and Medical University of Vienna receive payments for antibody assays (aquaporin-4 and other anti-neuronal and anti-glial antibodies) and for aquaporin-4 antibody validation assays organized by Euroimmun (Lübeck, Germany).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
